Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2MA0E
|
|||
| Drug Name |
IONIS-TMPRSS6-LRx
|
|||
| Drug Type |
Antisense oligonucleotide
|
|||
| Indication | Beta thalassemia [ICD-11: 3A50.2; ICD-10: D56.1, D56.3] | Phase 2 | [1] | |
| Company |
Ionis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TMPRSS6 messenger RNA (TMPRSS6 mRNA) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04059406) Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS TMPRSS6-LRx. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Ionis Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.